Increasing drug costs in the health care systems are a key issue on the political agenda. The result is growing price pressure on pharmaceutical companies. Optimized price and market access strategies along the entire product life cycle is becoming increasingly important. Homburg & Partner can help you find the suitable pricing and market access strategy for your product – from launch pricing to generics/biosimilar defense in mature markets. We offer customized solutions for all major EU countries as well as the US healthcare market.
Building on a comprehensive market analysis, the price readiness of various market participants is evaluated and translated into price recommendations. Our recommendations are always adapted to the needs of the respective reimbursement sector and the strategic objectives of the product. In order to enforce the identified prices on the market, we will also support you in designing a suitable contract strategy.
